Literature DB >> 10779029

Elective splenectomy in children with idiopathic thrombocytopenic purpura.

E Mantadakis1, G R Buchanan.   

Abstract

PURPOSE: The aim of this study was to review the safety and efficacy of elective splenectomy in children with idiopathic (immune) thrombocytopenic purpura (ITP).
METHODS: The authors reviewed the medical records of children with ITP treated with elective splenectomy at Children's Medical Center of Dallas since 1961. Indication for splenectomy was symptomatic thrombocytopenia unresponsive to medical management.
RESULTS: Thirty-eight evaluable patients who had elective splenectomy for ITP were identified. Twenty-one (55%) were girls and 17 (45%) were boys. Twenty-two had splenectomy since January 1990. Age at diagnosis ranged from 6 months to 15.9 years (median 9 years), and age at splenectomy ranged from 3.6 to 16.4 years (median 11.8). Laparoscopic splenectomy was performed in 11 patients. No patient died and only one (2.6%) had postoperative hemorrhage. There were no other complications related to surgery. No cases of postsplenectomy sepsis were observed. At follow-up ranging from 1 month to 19.9 years (median 2.1 years), 29 patients (76.3%) had a normal platelet count (>150 x 109/L) and 4 (10.5%) had a platelet count between 50 and 150 x 109/L. Only two of the five (13.2%) remaining patients who continued to have a platelet count less than 50 x 109/L had hemorrhagic manifestations necessitating intermittent therapy with corticosteroids.
CONCLUSION: Laparoscopic or open splenectomy is a safe and effective procedure for children with chronic or refractory ITP and should be considered when medical management fails or causes excessive toxicity.

Entities:  

Mesh:

Year:  2000        PMID: 10779029     DOI: 10.1097/00043426-200003000-00013

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  12 in total

Review 1.  Pediatric ITP: is it different from adult ITP?

Authors:  Jenny M Despotovic; Amanda B Grimes
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 2.  Childhood immune thrombocytopenia: Clinical presentation and management.

Authors:  Mohamed El Faki Osman
Journal:  Sudan J Paediatr       Date:  2012

3.  A cost-effectiveness study of intravenous immunoglobulin in childhood idiopathic thrombocytopenia purpura patients with life-threatening bleeding.

Authors:  Rosarin Sruamsiri; Piyameth Dilokthornsakul; Chayanin Pratoomsoot; Nathorn Chaiyakunapruk
Journal:  Pharmacoeconomics       Date:  2014-08       Impact factor: 4.981

4.  Contemporary pediatric splenectomy: continuing controversies.

Authors:  James H Wood; David A Partrick; Taru Hays; Angela Sauaia; Frederick M Karrer; Moritz M Ziegler
Journal:  Pediatr Surg Int       Date:  2011-05-28       Impact factor: 1.827

Review 5.  Treatment of immune thrombocytopenic purpura in children : current concepts.

Authors:  Aziza T Shad; Corina E Gonzalez; S G Sandler
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

6.  Laparoscopic splenectomy: the clinical practice guidelines of the European Association for Endoscopic Surgery (EAES).

Authors:  B Habermalz; S Sauerland; G Decker; B Delaitre; J-F Gigot; E Leandros; K Lechner; M Rhodes; G Silecchia; A Szold; E Targarona; P Torelli; E Neugebauer
Journal:  Surg Endosc       Date:  2008-02-22       Impact factor: 4.584

7.  Chronic immune thrombocytopenia in a child responding only to thrombopoietin receptor agonist.

Authors:  Mohamed E Osman
Journal:  Sudan J Paediatr       Date:  2012

8.  Thrombopoietin Receptor Agonist Use in Children: Data From the Pediatric ITP Consortium of North America ICON2 Study.

Authors:  Cindy Neunert; Jenny Despotovic; Kristina Haley; Michele P Lambert; Kerri Nottage; Kristin Shimano; Carolyn Bennett; Robert Klaassen; Kimo Stine; Alexis Thompson; Yves Pastore; Travis Brown; Peter W Forbes; Rachael F Grace
Journal:  Pediatr Blood Cancer       Date:  2016-05-02       Impact factor: 3.167

9.  American Society of Hematology 2019 guidelines for immune thrombocytopenia.

Authors:  Cindy Neunert; Deirdra R Terrell; Donald M Arnold; George Buchanan; Douglas B Cines; Nichola Cooper; Adam Cuker; Jenny M Despotovic; James N George; Rachael F Grace; Thomas Kühne; David J Kuter; Wendy Lim; Keith R McCrae; Barbara Pruitt; Hayley Shimanek; Sara K Vesely
Journal:  Blood Adv       Date:  2019-12-10

10.  Incidence and outcomes of refractory immune thrombocytopenic purpura in children: a retrospective study in a single institution.

Authors:  Masataka Ito; Hiroshi Yagasaki; Koji Kanezawa; Katsuyoshi Shimozawa; Maiko Hirai; Ichiro Morioka
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.